INTRODUCTION
Pneumococci, that are freshly isolated from infected tissue, have been shown to elaborate a neuraminidase (1) . The enzyme is secreted during the logarithmic phase of growth and cleaves terminal molecules of Nacetylneuraminic acid (NANA)' from glycoproteins and from gangliosides (2) (3) (4) (5) . If secreted into infected cerebrospinal fluid (CSF), neuraminidase might liberate NANA from exposed substrates such as CSF proteins, gangliosides, and the glycoproteins of neurons and other central nervous system (CNS) tissues. Moreover, if these substrates participate in the regulation of neural activity, molecular alterations induced by enzymatic activity might result in clinical manifestations of neuronal dysfuncton (6) (7) .
This study was undertaken to quantify the production of neuraminidase by pneumococci isolated from patients with meningitis, to assess the activity of the enzyme during infection by quantification of free and total CSF NANA, and to correlate these data with results of therapy in 35 patients with pneumococcal meningitis.
METHODS
Serum and CSF were collected from 36 patients with pneumococcal meningitis and from 14 of 22 patients with meningococcal meningitis. These patients comprised the majority of cases studied in Calcutta, India, during 1966 and 1967, to ascertain the effects of methylprednisolone in the treatment of bacterial meningitis (8) . Patients were selected for steroid therapy in a double-blind, block-randomized manner, and received a total dose of 1500 mg methylprednisolone during the first 4 days in hospital. Lumbar punctures were performed on days 1, 3 (48 hr after admission), 5, 7, and 14 of treatment in order to assess the effects of the drug. CSF Samples of H. influenzac were identified by colonial morphology and by X and V factor growth requirements. They were typed with commercial antiserum (Hyland Laboratories, Inc., Los Angeles, Calif.). Patients with H. influenzae meningitis ranged in age from 6 months to 6 yr and those with meningococcal disease ranged from 1 to 25 with a mean of 14 yr of age.
Meningococci and H. influenzae obtained in Seattle were tested for neuraminidase production within 10 days of isolation or immediately following removal from storage at -70'C. CSF obtained in Seattle was maintained at 40C following removal of leukocytes by centrifugation and tested for NANA within 3 wk of the onset of meningitis.
Controls consisted of patients subjected to lumbar puncture for reasons other than suspicion of acute bacterial meningitis. Nine patients from the Seattle Veterans Hospital ranged in age from 21 to 58 yr and 19 patients from Childrens Orthopedic Hospital ranged from 2 months to 10 yr of age.
Enzyme assays. Pneumococci were grown in Todd-Hewitt broth (Difco) and meningococci were cultured in Mueller-Hinton broth. which contained 1% enrichment additive (ISOVITALEX, Isovitalex, Baltimore Biological Laboratories, Cockeysville, Md.). Hemoglobin was added to this medium at a concentration of 1%o for cultivation of H.
influenzae.
Pneumococcal cultures were incubated aerobically at 37'C for 16 hr and viable organisms in each culture were estimated by inspection of pour plates containing 3% defibrinated rabbit blood. Broth cultures were centrifuged at 700 g for 30 min at 4'C, and portions of the supernatant broth were stored at -200C and tested 6 wk later.
Meningococci and H. influenzae were inoculated into 250 ml portions of medium and incubated at 370C in an atmosphere of 10% C02 for 24 hr. Abundance and purity of growth were confirmed by subculture on chocolate agar. Bacteria were removed by centrifugation at 700 g in the cold and protein was precipitated at 75% saturation with ammonium sulfate. Precipitates were taken up in small vol of distilled water such that nondialyzable bacterial proteins were concentrated 10-to 25-fold and then dialyzed in the cold against repeated changes of distilled water. 0.2 ml of this concentrate was incubated at 370 with 2.5 mg human alpha-i-acid glycoprotein (Calbiochem, Los Angeles, Calif. 90063), which had been dissolved in 0.8 ml of 0.15 M NaCl and buffered to pH 6.5 with 0.015 M phosphate, as substrate. After 60 min incubation, duplicate 0.4 ml samples were taken from the reaction mixture and analyzed for free NANA by the thiobarbituric acid assay of Warren with saline containing substrate as a negative control and crystalline NANA (Koch-Light Labs Ltd., Colnbrook, Buckinghampshire, England) as the standard (9). 0.6 ml portions of pneumococcal culture supernatants were analyzed with the same reagents except that 1.25 mg glycoprotein was dissolved in 2.4 ml of phosphate-buffered saline. Duplicate samples were assayed after 80 min incubation at 370 with Todd-Hewitt broth containing substrate as a negative control. Aldolase activity was assayed by the formation of N-acetyl-D-mannosamine according to the method of Brunetti, Jourdian, and Roseman (10). 0.5 ml portions of the reaction mixture were analyzed in duplicate Generously provided by Mrs. M. Meyer. (11) . Statistical analysis was performed according to standard procedures (12) . Enzyme neutralization test. A purified pneumococcal neuraminidase' (13) , was diluted in 0.15 M NaCl and buffered to pH 6.0 with 0.015 M phosphate such that 0.2 ml of the enzyme solution, when incubated with 0.2 ml collocalia mucoid (14) at 37'C for 60 min, and assayed for free NANA by the Warren method, produced an absorbance reading, corrected for a substrate blank, of 0.25 at 549 mA. To serial dilutions of serum and CSF, in a volume of 0.5 ml, 0.2 ml of this enzyme preparation was added. After mixing, we allowed the tubes to stand for 30 min at room temperature. 0.2 ml portions of collocalia mucoid were then added to each of the tubes and incubated for 60 min at 370C. Duplicate 0.2 ml samples of each reaction mixture were then read at 549 my. As controls, dilutions of CSF and serum were incubated separately with substrate in saline. Dilutions of CSF and serum showing a reduction of 50% or more in liberation of NANA, as compared with the positive control, were considered to show specific enzyme inhibition.
RESULTS
One patient with meningococcal meningitis died; however, none of those with Haemophilus influenzae meningitis died or had residual neurologic defects. 11 of 18 patients (61%) with pneumococcal meningitis and normal free NANA levels were cured, whereas only 4 of 17 patients (24%) with elevated values survived without residua (P < 0.10). Pneumonia, coma, and bacteremia were observed more often among pa- mannosamine detected per micromole of total NANA liberated (NANA plus N-acetyl-D-mannosamine), ranged from 1.5 to 14.7% with a mean of 6.0 ±3.1%. The relationship between colony-forming units and micromoles of total NANA liberated is illustrated in Fig. 1 tients with elevated than with normal free CSF NANA values (Table II) .
Rates of change toward normal for both free and total NANA concentrations are plotted in Fig. 3 . Included are all patients with pneumococcal meningitis, not cured, for whom any convalescent specimens were available (seven patients), and eight patients, who survived without residua, from whom at least three convalescent CSF samples were obtained. All convalescent specimens tested had normal free NANA levels even To analyze the potential contribution of leukocytes as a source of NANA, we separated leukocytes from normal human blood at room temperature in a 20% volume of 6% dextrose, washed them twice with Hanks balanced salt solution (HBSS), and adjusted them to a final concentration of 10;000 cells per mm' in HBSS. 0.4 ml of this suspension was analyzed for NANA following hydrolysis with sulfuric acid, as described in Methods, and found to yield 2.16 X 10' mg NANA/100 ml.
CSF total protein concentrations are compared with total CSF NANA levels for patients with meningococcal and H. influenzae meningitis in Fig. 4a . The number of observations is small, but a correlation is evident. This correlation was also observed for values derived from patients with pneumococcal meningitis and normal free CSF NANA levels (Fig. 4b) ; however, there is no correlation between total CSF NANA and CSF protein concentrations for patients with pneumococcal meningitis and evidence of neuraminidase activity, i.e., elevated free CSF NANA levels (Fig. 4c) .
In Table III , the percentage of free CSF NANA is related to coma and cure. CSF from 92% of patients had less than 30% or more than 70% liberation of NANA. Fewer patients in the low range manifested coma (24%) than in the high (55%), and cure was more common among those in the 0-30% free group (57%) than in those with 71-100% free/total ratio (18%) (P < 0.10).
Enzyme inhibition. Sufficient purified enzyme was available for analysis of acute CSF and serum from several patients with pneumococcal meningitis. Enzymeinhibiting activity was clearly present in both serum and spinal fluid of three patients (Table IV) . Serum titers rose significantly during the course of each patient's illness. bne CSF sample showed a slight rise after 7 days in hospital and two others fell significantly at a time when serum levels were highest. The increased titers of serum activity noted during convalescence and the associated drop in CSF titers, during the period of restoration of the blood-CSF barrier to normal, suggested that enzyme inhibitory activity was associated with humoral antibody. DISCUSSION Every strain of pneumococcus isolated from a patient with meningitis produced readily detectable amounts of neuraminidase. None of the strains of meningococci or H. influenzae secreted detectable enzyme. The number of isolates examined was small; however, each was freshly cultured from infected cerebrospinal fluid which contains the enzyme's substrate and which, therefore, may be con- sidered an excellent medium for the cultivation of enzyme-elaborating bacteria. Although the responsible organism was not analyzed for enzyme activity in every case of meningococcal meningitis, none of the cerebrospinal fluids from patients with meningococcal or H. influenzae meningitis showed elevated levels of free NANA, the split product of the enzyme's action. These observations suggest that neuraminidase is not secreted by meningococci or by H. influenzae.
NANA value derived from the CSF of our 28 control patients were in good agreement with the normal values given for free (0.42 ±0.14 mg/100 ml) and total (1.16 ±0.52 mg/100 ml) CSF NANA by Jakoby and Warren (11) . These investigators examined CSF from 170 pa- (19) raises the question of similar activity in vivo. The breakdown of the correlation between total NANA and CSF protein concentrations observed in patients with pneumococcal meningitis and evidence of neuraminidase activity (Fig.  4 c) provides inferential evidence that such activity occurs. Specifically, the very high ratio of total NANA to protein concentrations observed in certain patients can best be explained by postulating a source for free NANA in addition to that provided by serum glycoproteins in CSF.
It is not possible to explain fully the unusually low total NANA/protein concentration ratios observed in the infected CSF of some patients ( Fig. 4 c) ; however, a high degree of aldolase activity may be partially accountable. In addition, free NANA may be more rapidly cleared from the subarachnoid space than that which is bound. Free NANA, as a low molecular weight amino sugar, may enter into pathways similar to those responsible for regulation of CSF glucose concentrations (20) whereas bound NANA may be removed largely by bulk flow through arachnoid granulations with other particulate and macromolecular substances (21) .
In view of enzyme activity at the neuronal level implicated in this study, one is tempted to explain the high incidence of coma and adverse prognosis observed among patients with evidence of neuraminidase activity by assigning a causal role to neuraminidase. This relationship has been proposed by Kelly and Greiff who found the intracerebral injection of purified pneumococcal neuraminidase to be lethal for weanling mice (22) ; however, this hypothesis cannot be tested with absolute confidence by analysis of pneumococcal meningitis in man because of the interdependence of factors affecting survival. Review of our cases and those of others (23) (24) (25) (26) indicates that coma, bacteremia, and pneumonia are all associated with an adverse prognosis, and all but coma and, perhaps, pneumonia presumably exert their ill effects independently of neuraminidase activity. In our study, pneumonia, coma, and bacteremia were also associated with elevated free CSF NANA concentrations. Elevated CSF NANA levels cannot, therefore, be related to coma or death per se, because most of these patients also had pneumonia or bacteremia. The question of the pathogenicity of neuraminidase for man must be resolved by study of the enzyme's effects in an appropriate animal model.
